A meta-analysis of montelukast for recurrent wheeze in preschool children

被引:0
作者
Hasan R. Hussein
Atul Gupta
Simon Broughton
Gary Ruiz
Nicola Brathwaite
Cara J. Bossley
机构
[1] Kings College London,Faculty of Life Sciences & Medicine
[2] Kings College Hospital,Department of Respiratory Paediatrics
来源
European Journal of Pediatrics | 2017年 / 176卷
关键词
Recurrent wheeze; Meta-analysis; Montelukast; Efficacy;
D O I
暂无
中图分类号
学科分类号
摘要
There is conflicting evidence of the effectiveness of montelukast in preschool wheeze. A recent Cochrane review focused on its use in viral-induced wheeze; however, such subgroups are unlikely to exist in real life and change with time, recently highlighted in an international consensus report. We have therefore sought to investigate the effectiveness of montelukast in all children with preschool wheeze (viral-induced and multiple-trigger wheeze). The PubMed, Cochrane Library, Ovid Medline and Ovid EMBASE were screened for randomised controlled trials (RCTs), examining the efficacy of montelukast compared with placebo in children with the recurrent preschool wheeze. The primary endpoint examined was frequency of wheezing episodes. Five trials containing 3960 patients with a preschool wheezing disorder were analysed. Meta-analyses of studies of intermittent montelukast showed no benefit in preventing episodes of wheeze (mean difference (MD) 0.07, 95% confidence interval (CI) −0.14 to 0.29; mean for montelukast 2.68 vs placebo 2.54 (p = 0.5)), reducing unscheduled medical attendances (MD −0.13, 95% CI −0.33 to 0.07; mean for montelukast 1.62 vs placebo 1.78 (p = 0.21)) and reducing oral corticosteroids (MD −0.06, 95% CI −0.16 to 0.02; mean for montelukast 0.35 vs placebo 0.36 (p = 0.25)). The pooled results of the continuous regimen showed no significant difference in the number of wheezing episodes between the montelukast and placebo groups (MD −0.40, 95% CI −1.00 to 0.19; mean for montelukast 2.05 vs placebo 2.37 (p = 0.18)).
引用
收藏
页码:963 / 969
页数:6
相关论文
共 101 条
  • [21] Johnston SL(undefined)undefined undefined undefined undefined-undefined
  • [22] Gilles L(undefined)undefined undefined undefined undefined-undefined
  • [23] Menten J(undefined)undefined undefined undefined undefined-undefined
  • [24] Tozzi CA(undefined)undefined undefined undefined undefined-undefined
  • [25] Polos P(undefined)undefined undefined undefined undefined-undefined
  • [26] Brand PL(undefined)undefined undefined undefined undefined-undefined
  • [27] Caudri D(undefined)undefined undefined undefined undefined-undefined
  • [28] Eber E(undefined)undefined undefined undefined undefined-undefined
  • [29] Gaillard EA(undefined)undefined undefined undefined undefined-undefined
  • [30] Garcia-Marcos L(undefined)undefined undefined undefined undefined-undefined